Centre for Fetal Programming, Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
PLoS One. 2013;8(1):e53059. doi: 10.1371/journal.pone.0053059. Epub 2013 Jan 9.
Vitamin D has been hypothesized to reduce risk of pregnancy complications such as preeclampsia, gestational diabetes mellitus, and preterm delivery. However, many of these outcomes are rare and require a large sample size to study, representing a challenge for cohorts with a limited number of preserved samples. The aims of this study were to (1) identify predictors of serum 25-hydroxy-vitamin D (25(OH)D) among pregnant women in a subsample (N = 1494) of the Danish National Birth Cohort (DNBC) and (2) develop and validate a score predicting 25(OH)D-status in order to explore associations between vitamin D and maternal and offspring health outcomes in the DNBC. In our study sample, 42.3% of the population had deficient levels of vitamin D (<50 nmol/L 25(OH)D) and average levels of 25(OH)D-status were 56.7(s.d. 24.6) nmol/L. A prediction model consisting of intake of vitamin D from diet and supplements, outdoor physical activity, tanning bed use, smoking, and month of blood draw explained 40.1% of the variance in 25(OH)D and mean measured 25(OH)D-level increased linearly by decile of predicted 25(OH)D-score. In total 32.2% of the women were placed in the same quintile by both measured and predicted 25(OH)D-values and 69.9% were placed in the same or adjacent quintile by both methods. Cohen's weighted kappa coefficient (Κ = 0.3) reflected fair agreement between measured 25(OH)D-levels and predicted 25(OH)D-score. These results are comparable to other settings in which vitamin D scores have shown similar associations with disease outcomes as measured 25(OH)D-levels. Our findings suggest that predicted 25(OH)D-scores may be a useful alternative to measured 25(OH)D for examining associations between vitamin D and disease outcomes in the DNBC cohort, but cannot substitute for measured 25(OH)D-levels for estimates of prevalence.
维生素 D 被认为可以降低妊娠并发症的风险,如子痫前期、妊娠糖尿病和早产。然而,这些结果中有许多是罕见的,需要大样本量进行研究,这对于保存样本数量有限的队列来说是一个挑战。本研究的目的是:(1) 在丹麦国家出生队列(DNBC)的一个亚组(N=1494)中确定孕妇血清 25-羟维生素 D(25(OH)D)的预测因素;(2) 开发和验证一种预测 25(OH)D 状态的评分,以探索维生素 D 与 DNBC 中母婴健康结局之间的关联。在我们的研究样本中,42.3%的人群维生素 D 水平不足(<50 nmol/L 25(OH)D),25(OH)D 状态的平均水平为 56.7(s.d. 24.6) nmol/L。一个由饮食和补充剂、户外活动、日光浴床使用、吸烟和采血月份摄入的维生素 D 组成的预测模型解释了 25(OH)D 变异的 40.1%,预测的 25(OH)D 评分的十位数与平均测量的 25(OH)D 水平呈线性增加。总共有 32.2%的女性通过测量和预测的 25(OH)D 值被归入同一五分位数,69.9%的女性通过两种方法被归入相同或相邻的五分位数。测量的 25(OH)D 水平与预测的 25(OH)D 评分之间的 Cohen 加权 Kappa 系数(Κ=0.3)反映了两者之间的一致性一般。这些结果与其他环境中维生素 D 评分与疾病结果的关联与测量的 25(OH)D 水平相似。我们的研究结果表明,预测的 25(OH)D 评分可能是替代测量的 25(OH)D 来检查维生素 D 与 DNBC 队列中疾病结果之间关联的一种有用方法,但不能替代测量的 25(OH)D 水平来估计患病率。